secwatch.observer — SEC 8-K summary
======================================

Issuer:     SI-BONE, Inc. (SIBN)
CIK:        0001459839
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001459839-24-000075
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SI-BONE reports Q3 revenue $40.3M (+19% YoY); expects positive Adjusted EBITDA in Q4
--------------------------------------------------------------------------------

- Worldwide revenue $40.3M (+19% YoY); U.S. revenue $38.3M (+18% YoY).
- Net loss improved 34% to $6.6M; Adjusted EBITDA loss narrowed 94% to $0.2M.
- Over 1,200 active U.S. physicians (+15%); commercialized iFuse TORQ TNT for pelvic fractures.
- Updated FY2024 revenue guidance to $165-166M (prev $165-167M); expects Adj EBITDA positive in Q4.
- Refinanced $36M term loan, lowered borrowing cost, extended maturity to 2029.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1459839/000145983924000075/0001459839-24-000075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1459839/000145983924000075/sibn-20241112.htm
  HTML page:      https://secwatch.observer/filing/0001459839-24-000075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer